Market Overview

Why Vaccinex's Stock Is Trading Lower Today

Share:
Why Vaccinex's Stock Is Trading Lower Today

Vaccinex (NASDAQ: VCNX) shares are trading lower on Wednesday after BTIG downgraded the stock from Buy to Neutral.

Vaccinex is a clinical-stage biotechnology company. It is engaged in the discovery and development of targeted biotherapeutics to treat serious diseases and conditions with unmet medical needs, including cancer, neurodegenerative diseases, and autoimmune disorders. The company's product pipeline includes pepinemab (VX15) Neurology, VX5 Autoimmune, and others.

Vaccinex shares were trading down 15.09% at $1.97 at the time of publication. The stock has a 52-week high of $12.23 and a 52-week low of $1.95.

Latest Ratings for VCNX

DateFirmActionFromTo
Sep 2020OppenheimerMaintainsOutperform
Sep 2020BTIGDowngradesBuyNeutral
Sep 2018OppenheimerInitiates Coverage OnOutperform

View More Analyst Ratings for VCNX
View the Latest Analyst Ratings

 

Related Articles (VCNX)

View Comments and Join the Discussion!

Posted-In: why it's movingPenny Stocks Downgrades Analyst Ratings

Latest Ratings

StockFirmActionPT
INTCJP MorganMaintains70.0
STMCanaccord GenuityMaintains47.0
ELDeutsche BankMaintains248.0
UAADeutsche BankMaintains13.0
INTCDeutsche BankMaintains55.0
View the Latest Analytics Ratings
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com